RSSS Research Solutions Inc

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K/A

(Amendment No. 1)

 

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report:

(Date of earliest event reported)

 

December 1, 2023

 

 

Research Solutions, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada

(State or other Jurisdiction of Incorporation)

 

1-39256		11-3797644
(Commission File Number)		(IRS Employer Identification No.)

 

N/A

(Address of principal executive offices and
Zip Code)

 

(310) 477-0354

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

 

¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class	Trading Symbol(s)	Name of each Exchange on which  registered
Common stock, $0.001 par value	RSSS	The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company     ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ¨

 

 

 

EXPLANATORY NOTE

 

On November 24, 2023, Research Solutions, Inc., a Nevada corporation (the “Registrant”), Research Solutions Acquisition 2, LLC, a Delaware limited liability company and a wholly-owned subsidiary of the Registrant (“Merger Sub”), Scite, Inc., a Delaware corporation (“Scite”), and Shareholder Representative Services LLC, a Colorado limited liability company, solely in its capacity as the representative, agent and attorney-in-fact of Scite’s securityholders, entered into an Agreement of Merger and Plan of Reorganization (the “Merger Agreement”), governing Scite’s merger with and into Merger Sub (the “Merger”), with Merger Sub continuing its existence under the name “Scite, LLC” as the surviving entity after the Merger and a wholly-owned subsidiary of the Registrant. Capitalized terms used herein but not otherwise defined shall have the meanings ascribed to them in the Merger Agreement.

 

On December 1, 2023, the Registrant filed with the Securities and Exchange Commission a Current Report on Form 8-K (the “Original 8-K”) reporting the consummation of the Merger. This amendment to the Original 8-K amends Item 9.01 of the Original 8-K and provides the historical financial information required pursuant to Item 9.01(a) of Form 8-K and the pro forma financial information required pursuant to Item 9.01(b) of Form 8-K.

 

Item 9.01. Financial Statements and Exhibits.

 

(a) Financial Statements of Businesses Acquired.

 

The audited balance sheet of Scite as of June 30, 2023, and the related statement of operations, stockholders’ equity and cash flows for the fiscal years ended June 30, 2023, along with the accompanying notes and the independent auditor's report related thereto, are included as Exhibit 99.1 to this report and incorporated by reference herein.

 

The unaudited interim condensed balance sheets of Scite as of September 30, 2023 and June 30, 2023 and the related statement of operations, stockholders’ equity and cash flows for the three months ended September 30, 2023, along with the accompanying notes, are included as Exhibit 99.2 to this report and incorporated by reference herein.

 

(b) Pro Forma Financial Information.

 

The Registrant’s unaudited pro forma condensed combined balance sheet as of September 30, 2023 and unaudited pro forma condensed combined statement of operations for the three months ended September 30, 2023 and the year ended June 30, 2023, along with the accompanying notes, giving effect to the Merger, are included as Exhibit 99.3 to this report and incorporated by reference herein.

 

(d)            Exhibits.

 

Exhibit No.	Description
23.1	Consent of Independent Registered Public Accounting Firm.
99.1	Audited Financial Statements of Scite as of June 30, 2023 and for the fiscal year ended June 30, 2023.
99.2	Unaudited Financial Statements of Scite as of September 30, 2023 and for the three months ended September 30, 2023.
99.3	Unaudited Pro Forma Condensed Combined Financial Information of Research Solutions, Inc.
104	Cover Page Interactive Data File (embedded as Inline XBRL document).

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

	RESEARCH SOLUTIONS, INC.
Date: February 7, 2024	By:	/s/ William Nurthen
		William Nurthen
		Chief Financial Officer & Secretary

 

 

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the following Registration Statement on Form S-1 (No. 333-212649), Registration Statement on Form S-3 (No. 333-276240) and Registration Statements on Form S-8 (Nos. 333-169823, 333-185059, 333-200656, 333-214824, 333-221963, 333-235261, 333-250799, 333-261275) of Research Solutions, Inc. and Subsidiaries of our report dated February 7, 2024, relating to the financial statement of Scite, Inc. as of June 30, 2023 and for the year then ended, which is included in this Current Report on Form 8-K/A dated February 7, 2024.

 

/s/ Weinberg & Company, P.A.

February 7, 2024

Los Angeles, California

 

 

 

Exhibit 99.1

 

SCITE, INC.

FINANCIAL STATEMENTS

FOR THE YEAR ENDED

JUNE 30, 2023

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Shareholders

Scite, Inc.

Brooklyn, NY

 

Opinion on the Financial Statements

 

We have audited the accompanying balance sheet of Scite, Inc. (the “Company”) as of June 30, 2023, the related statements of operations, shareholders’ equity, and cash flows for the year then ended and the related notes (collectively referred to as the “financial statements”).  In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2023, and the results of its operations and its cash flows for the year then ended in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting.  As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audit included performing procedures to assess the risks of material misstatement, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.  We believe that our audit provides a reasonable basis for our opinion.

 

We have served as the Company’s auditor since 2023.

 

/s/ Weinberg & Company, P.A.

 

Los Angeles, California

 

February 7, 2024

 

 

SCITE, INC.

BALANCE SHEET

 

		June 30, 2023
Assets
Current Assets:
Cash and cash equivalents		$	1,153,292
Accounts receivable			153,271
Total current assets			1,306,563
Property and equipment, net of accumulated depreciation of $4,063			3,177
Total assets		$	1,309,740
Liabilities and Shareholders’ Equity
Current Liabilities:
Accounts payable and other current liabilities		$	9,113
Deferred revenue			250,702
Total current liabilities			259,815
Shareholders’ equity:
Preferred stock, Series Seed 1 and 2, $0.0001 par value, 4,996,741 shares authorized, 4,996,741 shares issued and outstanding			500
Common stock, $1.0001 par value, 14,837,676 shares authorized; 8,550,000 shares issued; 7,446,223 shares outstanding			855
Additional paid-in capital			2,023,593
Accumulated deficit			(974,913	)
Treasury stock, at cost, 1,103,777 shares			(110	)
Total shareholders’ equity			1,049,925
Total liabilities and shareholders’ equity		$	1,309,740

 

See accompanying notes to the financial statements.

 

 

SCITE, INC.

STATEMENT OF OPERATIONS

For the Year Ended June 30, 2023

 

Revenue:
Trade		$	923,154
Grant			198,045
Total revenue			1,121,199
Cost of revenue			199,552
Gross profit			921,647
Selling, general and administrative expenses			1,332,175
Loss before provision for income tax			(410,528	)
Provision for income tax			2,276
Net loss		$	(412,804	)

 

See accompanying notes to the financial statements.

 

 

SCITE, INC.

STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY

FOR THE YEAR ENDED JUNE 30, 2023

 

 

																						Additional
	Preferred Stock							Common Stock							Treasury Stock							Paid-in			Retained
	Shares				Amount			Shares				Amount			Shares				Amount			Capital			Earnings			Total
Balance, June 30, 2022		-			$	-			8,550,000			$	855			(1,103,777	)		$	(110	)	$	73,837		$	(562,109	)	$	(487,527	)
Issuance of preferred shares for cash		2,909,231				291			-				-			-				-			1,499,709						1,500,000
Conversion of notes payable and accrued interest into preferred shares		2,087,510				209																	430,236						430,445
Stock-based compensation																							19,811						19,811
Net loss		-				-			-				-			-				-						(412,804	)		(412,804	)
Balance, June 30, 2023		4,996,741			$	500			8,550,000			$	855			(1,103,777	)		$	(110	)	$	2,023,593		$	(974,913	)	$	1,049,925

 

See accompanying notes to the financial statements.

 

 

SCITE, INC.

STATEMENT OF CASH FLOWS

For the Year Ended June 30, 2023

 

Cash flows from operating activities:
Net loss		$	(412,804	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation			1,448
Stock based compensation			19,811
Changes in operating assets and liabilities:
Accounts receivable			(114,226	)
Accounts payable and other current liabilities			13,947
Deferred revenue			66,658
Net cash provided by used in operating activities			(425,166	)
Cash flows from financing activities:
Proceeds from issuance of preferred stock			1,500,000
Net cash provided by financing activities			1,500,000
Net increase in cash and cash equivalents			1,074,834
Cash and cash equivalents, beginning of the year			78,458
Cash and cash equivalents, end of the year		$	1,153,292
Supplemental disclosures of cash flow information:
Cash paid during the period for:
Interest		$	-
Income taxes paid			2,276
Noncash investing and financing activities:
Conversion of notes payable and accrued interest into preferred shares		$	430,445

 

See accompanying notes to the financial statements.

 

 

SCITE, INC.

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED JUNE 30, 2023

 

NOTE 1. NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of Business

 

Scite, Inc. is a Brooklyn, New York based start-up company that helps researchers better discover, understand and evaluate research articles through Smart-Citation which are citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence.

 

The Company’s citation platform called Scite, uses deep learning, natural language processing, and a network of experts to identify and promote reliable research by evaluating the accuracy of scientific claims. Scite, can automatically classify scientific citations as supporting, refuting or mentioning, which enables the entity to score the accuracy of scientific reports, researchers, institutions journals and scientific fields using a measure called scite.

 

The Company's customers primarily consist of research students as well as colleges and universities.

 

Basis of presentation

 

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

 

Use of Estimates

 

In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenue and expenses during the reported period. Actual results could differ from these estimates.

 

Revenue Recognition

 

The Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers. The guidance requires the Company to recognize revenue to depict the transfer of services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those services. The guidance also requires disclosures related to the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers.

 

 

The Company’s sources of revenue during the year ended June 30, 2023, are as follows:

 

a)

Subscription and License Revenue

 

The Company derives its license revenue from subscription agreements with customers for access to the Company’s citation platform. The Company offers monthly or annual subscriptions/licenses to its customers. The subscription/license revenue is recognized evenly over the life of the contract as the Company considers the contract to be one performance obligation. Contract liabilities include deferred revenues related to advanced payments for license agreements which are amortized over the life of the contract which is typically one month to one year. Contract liabilities totaled $250,702 at June 30, 2023, and are expected to be recognized in the next year.

 

b)

Grant Revenue

 

During the year ended June 30, 2023, the Company recognized grant revenue of $198,045. We concluded that payments received under these grants represent conditional, nonreciprocal contributions, as described in ASC 958, Not-for-Profit Entities, and that the grants are not within the scope of ASC 606, Revenue from Contracts with Customers, as the organizations providing the grants do not meet the definition of a customer. Grant and contract funded program activities are normally billed as work progresses and revenues are recognized as expenses specific to the grant are incurred.

 

Cash and Cash Equivalents

 

Cash and cash equivalents include unrestricted deposits and short-term investments with an original maturity of three months or less.

 

Accounts Receivable

 

Accounts receivable are recorded at their estimated net realizable value, net of an allowance for doubtful accounts. The Company's estimate of the allowance for doubtful accounts is based upon historical experience, its evaluation of the current status of receivables, and unusual circumstances, if any. Accounts are considered past due if payment is not made on a timely basis in accordance with the Company's credit terms. Accounts considered uncollectible are charged to revenue against the allowance. As of September 30, 2023 management did not consider it necessary to record an allowance for doubtful accounts.

 

Property and Equipment

 

Property and equipment are stated at cost. Maintenance and repairs of property and equipment are expensed as incurred and major improvements are capitalized. Upon retirement, sale or other disposition of property and equipment, the cost and accumulated depreciation are eliminated from the accounts and gain or loss is included in operations. Depreciation of property and equipment is computed on the straight-line method over the useful lives of the computers of five years.

 

Advertising

 

Advertising costs are expensed as incurred and are included in selling, general and administrative expenses in the amount of $146,975 for the year ended June 30, 2023.

 

 

 

Income Taxes

 

The Company accounts for income taxes in accordance with FASB ASC 70, Income Taxes, which requires the recognition of deferred income taxes for differences between the basis of assets and liabilities for financial statement and income tax purposes. Deferred tax assets and liabilities represent future tax consequences for those differences, which will either be deductible or taxable when the assets and liabilities are recovered and settled. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized. Based upon all available evidence, management concluded that it was more-likely-than-not that its deferred tax assets would not be realized, and therefore a full valuation allowance was in place as of June 30, 2023.

 

The Company follows the provisions of FASB ASC 740-10-25, which prescribes a recognition threshold and measurement attribute for the recognition and measurement of tax positions or expected to be taken in income tax returns. FASB ASC 740-10-25 also provides guidance on de-recognition of income taxes assets and liabilities, classification of current and deferred income taxes and liabilities, and accounting for interest and penalties associated with tax positions.

 

The Company has not been recently audited by the IRS or state agencies; and accordingly, the business tax returns for the past three years are open to examination. The Company has evaluated its tax positions and has concluded that they do not result in anything that would require either recording or disclosure in the financial statements based upon the criteria set forth in ASC 740.

 

Fair Value Measurements

 

The Company uses various inputs in determining the fair value of its investments and measures these assets on a recurring basis. Financial assets recorded at fair value in the balance sheets are categorized by the level of objectivity associated with the inputs used to measure their fair value. ASC Topic 820 defines the following levels directly related to the amount of subjectivity associated with the inputs:

 

Level 1      Quoted prices in active markets for identical assets or liabilities.

Level 2      Inputs, other than the quoted prices in active markets, that is observable either directly or indirectly.

Level 3      Unobservable inputs based on the Company’s assumptions.

 

As of June 30, 2023, the carrying value of financial assets and liabilities such as cash, accounts receivable, and accounts payable and other current liabilities approximates their fair value because of the short-term maturity of these instruments. Unless otherwise noted, it is management's opinion that the Company is not exposed to significant interest, currency or credit risks arising from these financial instruments.

 

 

Concentrations of Credit Risk

 

The Company's financial statements that are subject to credit risk consist primarily of cash and trade receivables. At times throughout the year, the Company's cash balances exceeded amounts insured by the Federal Deposit Insurance Company (FDIC). However, the Company believes it is not exposed to any significant credit risk related to these cash accounts.

 

At June 30, 2023, the Company had accounts receivable from two customers which comprised 46% and 18% of its accounts receivable balance, respectively. During the year ended June 30, 2023, no customers accounted for more than 10% of the Company’s revenue.

 

Stock Based Compensation

 

The Company periodically issues stock options to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, Compensation-Stock Compensation whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.

 

The fair value of each option grant is estimated using the Black-Scholes option-pricing model. The Company is a private company and lacks company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of peer companies within the technology industry with characteristics similar to the Company. The expected term of the Company’s stock options has been determined utilizing the “simplified” method for awards that qualify as “plain vanilla” options. The expected term of stock options granted to non-employees is equal to the contractual term of the option award. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is zero, based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future.

 

During the year ended June 30, 2023, shares of common stock of the Company (the “Common Stock”) were not publicly traded. As such, during the period, the Company estimated the fair value of common stock using an appropriate valuation methodology, in accordance with the framework of the American Institute of Certified Public Accountants’ Technical Practice Aid, Valuation of Privately-Held Company Equity Securities Issued as Compensation. Each valuation methodology includes estimates and assumptions that require the Company’s judgment. These estimates and assumptions include a number of objective and subjective factors, including external market conditions, guideline public company information, the prices at which the Company sold its preferred stock to third parties in arms’ length transactions, the rights, and preferences of securities senior to the Common Stock at the time, and the likelihood of achieving a liquidity event such as an initial public offering or sale. Significant changes to the assumptions used in the valuations could result in different fair values of stock options at each valuation date, as applicable.

 

 

NOTE 2. PROPERTY AND EQUIPMENT

 

Property and equipment consist of the following at June 30, 2023.

 

Computers		$	7,240
Accumulated depreciation			(4,063	)
		$	3,177

 

Depreciation expense related to property and equipment was $1,448 for the year ended June 30, 2023.

 

NOTE 3. STOCK OPTION PLANS

 

In 2018, the Company established the Scite, Inc. Stock Incentive Plan (“The Plan”). Under the Plan, which covers all employees, officers and directors, as well as consultants and advisors, the Company may grant Common Stock in officers and directors, as well as consultants and advisors, the Company may grant shares of Common Stock in the form of incentive stock options (“ISO”) or non-statutory stock options (“NSO”). Options grants generally vest over two to four years and vest options are available to exercise for 90 days following an employee's departure. A qualified liquidation event prior to the end of the vesting schedule will trigger a full acceleration of the exercisability of outstanding incentive awards held by some or all participants, provided that the Committee, in its sole discretion, may condition such acceleration.

 

The exercise price of the options may not be granted at less than fair market value of the common stock on the date of the grant. Stock-based compensation cost is measured at the grant date, based on the fair value of the awards that are ultimately expected to vest, and recognized on a straight-line basis over the requisite service period, which is generally the vesting period.

 

The following is an analysis of options to purchase shares of the Company's stock issued and outstanding as of June 30, 2023:

 

Options outstanding at the beginning of the year			460,050
Granted			-
Options exercised			-
Forfeited			-
Options outstanding at the beginning of the year			460,050

 

The weighted average remaining contractual life of all options outstanding as of June 30, 2023 was 6.92 years. The remaining contractual life for options vested and exercisable at June 30, 2023 was 6.85 years. Furthermore, the aggregate intrinsic value of options outstanding as of June 30, 2023 was approximately $76,000, and the aggregate intrinsic value of options vested and exercisable as of June 30, 2023 was approximately $62,000, in each case based on the fair value of the Common Stock on June 30, 2023.

 

During the year ended June 30, 2023, the Company did not grant any options to employees. The total fair value of options that vested during the year ended June 30, 2023 was $19,811 and is included in selling, general and administrative expenses in the accompanying statement of operations. As of June 30, 2023, the amount of unvested compensation related to stock options was approximately $24,000 which will be recorded as an expense in future periods as the options vest.

 

 

NOTE 4. PREFERRED STOCK

 

During the year ended June 30, 2023, the Company issued 2,909,231 shares of Series Seed 1 Preferred Stock (as defined in that certain Amended and Restated Certificate of Incorporation of Company (the “Charter”)) for gross proceeds to the Company of $1,500,000. During the year ended June 30, 2023, the Company issued 2,087,510 shares of Series Seed 2 Preferred Stock (as defined in the Charter) upon the conversion of notes payable and accrued interest in the aggregate of $430,445.

 

Dividends

 

Each share is entitled to dividends as and when declared by the Board of Directors of the Company in an amount equal to 7% per annum. If an Event of Default (as defined in the Charter) should occur, the rate of the Accruing Dividends (as defined in the Charter) shall automatically increase to ten percent from and after such Event of Default.

 

Voting

 

On any matter presented to the stockholders of the Company for their action or consideration at any meeting of stockholders of the Company (or by written consent of stockholders in lieu of meeting), each holder of outstanding shares of Series Seed Preferred Stock (as defined in the Charter) shall be entitled to cast the number of votes equal to the number of whole shares of Common Stock into which the shares of Series Seed Preferred Stock held by such holder are convertible as of the record date for determining stockholders entitled to vote on such matter.

 

Conversion

 

Each share of Series Seed Preferred Stock shall be convertible, at the option of the holder thereof, at any time and from time to time, and without the payment of additional consideration by the holder thereof, into such number of fully paid and nonassessable shares of Common Stock as is determined by dividing the Series Seed Original Issue Price (as defined in the Charter), by the applicable Conversion Price in effect at the time of conversion. The “Conversion Price” shall initially mean, $0.5156 with respect to the Series Seed-1 Preferred Stock (as defined in the Charter), and $0.2062 per share, with respect to the Series Seed-2 Preferred Stock (as defined in the Charter).

 

Liquidation

 

In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company or any Deemed Liquidation Event (as defined in the Charter), the holders of shares of Series Seed Preferred Stock then outstanding shall be entitled to be paid out of the assets of the Company available for distribution to its stockholders, and in the event of a Deemed Liquidation Event, the holders of shares of Series Seed Preferred Stock then outstanding, on a pari passu basis, shall be entitled to be paid out of the consideration payable to stockholders in such Deemed Liquidation Event or out of the Available Proceeds (as defined in the Charter), as applicable, before any payment shall be made to the holders of Common Stock by reason of their ownership thereof, an amount per share equal to the greater of (i) the applicable Original Issue Price (as defined in the Charter), plus any Accruing Dividends accrued but unpaid thereon, whether or not declared, together with any other dividends declared but unpaid thereon, or (ii) such amount per share as would have been payable had all shares of Series Seed Preferred Stock been converted into Common Stock pursuant to the agreement immediately prior to such liquidation, dissolution, winding up or Deemed Liquidation Event. If upon any such liquidation, dissolution or winding up of the Company or Deemed Liquidation Event, the assets of the Company available for distribution to its stockholders shall be insufficient to pay the holders of shares of Series Seed Preferred Stock the full amount to which they shall be entitled under the agreement, the holders of shares of Series Seed Preferred Stock shall share ratably in any distribution of the assets available for distribution in proportion to the respective amounts which would otherwise be payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid in full.

 

 

NOTE 5. NOTES PAYABLE

 

As of June 30, 2022, the Company had outstanding notes payable to certain third parties in the aggregate amount of $350,000. The notes bore interest rate of 6% per annum and were due June 1, 2022. As of June 30, 2022, accrued interest on the notes was $75,612. During the year ended June 30, 2023, the Company accrued interest on the notes of $4,833. In September 2022, the Company issued 2,087,510 shares of Series Seed-2 Preferred Stock to convert the outstanding principal of $350,000 and accrued interest of $80,445, in accordance with the original conversion terms. There was no outstanding notes payable as of September 30, 2023.

 

NOTE 6. COMMITMENTS & CONTINGENCIES

 

Sales to certain consumers may be subject to sales tax requirements and possible audits by state taxing authorities. The Company records its estimated sales tax liability and includes that amount as an accrued obligation until paid.

 

Legal Proceedings

 

From time to time, we are a party to claims and legal proceedings arising in the ordinary course of business. Although management of the Company cannot predict the ultimate outcome of these legal proceedings with certainty, it believes that the ultimate resolution of the Company’s legal proceedings, including any amounts it may be required to pay, will not have a material effect on the Company’s financial statements.

 

NOTE 7. INCOME TAXES

 

The provision for income taxes consists of the following for the year ended June 30, 2023:

 

Current
Federal		$	-
State			2,276
Deferred
Federal			-
State			-
Provision for income tax		$	2,276

 

 

The reconciliation of the effective income tax rate to the federal statutory rate is as follows:

 

Federal income tax rate			21	%
State tax			5	%
Change in valuation allowance			(26.6	)%
Provision for income tax			0.6	%

 

Deferred taxes are provided for the differences in the tax and accounting basis of assets and liabilities as of June 30, 2023, as follows:

 

Deferred tax assets
Net operating loss carryforwards		$	232,168
Total deferred tax assets			232,168
Deferred tax liabilities
Accumulated depreciation			(4,062	)
Total deferred tax liabilities			(4,062	)
Net deferred tax assets			228,106
Less:  Valuation allowance			(228,106	)
Net deferred tax assets		$	-

 

At June 30, 2023, the Company has gross net operating loss (“NOL”) carryforwards for federal and state income tax purposes of approximately $812,000 and $807,000, respectively. The federal NOL’s do not expire. The state NOL’s expire between the years 2038 and 2042. The Company’s ability to use its NOL carryforwards may be limited if it experiences an “ownership change” as defined in Section 382 (“Section 382”) of the Internal Revenue Code of 1986, as amended. An ownership change generally occurs if certain stockholders increase their aggregate percentage ownership of a corporation’s stock by more than 50 percentage points over their lowest percentage ownership at any time during the testing period, which is generally the three-year period preceding any potential ownership change.

 

At June 30, 2023, the Company had taken no uncertain tax positions that would require disclosure under ASC 740, Accounting for Income Taxes.

 

NOTE 8. SUBSEQUENT EVENTS

 

On November 24, 2023, the Company, Research Solutions, Inc.  (NASDAQ: RSSS) and Research Solutions Acquisition 2, LLC, a Delaware limited liability company and a wholly-owned subsidiary of the Registrant (“Merger Sub”) entered into an Agreement and Plan of Merger, governing the Company’s merger with and into Merger Sub (the “Merger”), with Merger Sub continuing its existence under the name “Scite, LLC” (the “Surviving Entity”) as the surviving entity after the Merger and a wholly-owned subsidiary of the Registrant at the effective time of the Merger. The transaction closed on December 1, 2023.

 

 

 

Exhibit 99.2

 

SCITE, INC.

CONDENSED FINANCIAL STATEMENTS

FOR THE PERIOD ENDED

SEPTEMBER 30, 2023

 

 

SCITE, INC.

CONDENSED BALANCE SHEETS

 

		September 30, 2023 (Unaudited)				June 30, 2023
Assets
Current Assets:
Cash and cash equivalents		$	1,359,340			$	1,153,292
Accounts receivable			108,001				153,271
Total current assets			1,467,341				1,306,563
Property and equipment, net of accumulated depreciation of $4,425 and $4,063, respectively			2,815				3,177
Total assets		$	1,470,156			$	1,309,740
Liabilities and Shareholders’ Equity
Current Liabilities:
Accounts payable and other current liabilities		$	23,218			$	9,113
Deferred revenue			266,903				250,702
Total liabilities			290,121				259,815
Shareholders’ equity:
Preferred stock, Seed 1 and 2, $0.0001 par value, 4,996,741 shares authorized, 4,996,741 shares issued and outstanding as of September 30, 2023 and June 30, 2023			500				500
Common stock, $1.0001 par value, 14,837,676 shares authorized; 8,550,000 shares issued; 6,457,381 and 7,446,223 shares outstanding at September 30, 2023 and June 30, 2023, respectively			855				855
Additional paid-in capital			2,029,205				2,023,593
Retained earnings (accumulated deficit)			(850,398	)			(974,913	)
Treasury stock, at cost, 2,092,619 and 1,103,777 shares at September 30, 2023 and June 30, 2023, respectively			(127	)			(110	)
Total shareholders’ equity			1,180,035				1,049,925
Total liabilities and shareholders’ equity)		$	1,470,156			$	1,309,740

 

See accompanying notes to the condensed financial statements.

 

 

SCITE, INC.

CONDENSED STATEMENT OF OPERATIONS

For the Period Ended September 30, 2023

(Unaudited)

 

Revenue		$	732,634
Cost of revenue			60,652
Gross profit			671,982
Selling, general and administrative expenses			547,467
Net income		$	124,515

 

See accompanying notes to the condensed financial statements.

 

 

SCITE, INC.

CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY

FOR THE PERIOD ENDED SEPTEMBER 30, 2023

(Unaudited)

																	Additional
		Preferred Stock					Common Stock					Treasury Stock					Paid-in			Retained
		Shares		Amount			Shares		Amount			Shares		Amount			Capital			Earnings			Total
Balance, June 30, 2023		4,996,741		$	500		8,550,000		$	855		(1,103,777	)	$	(110	)	$	2,023,593		$	(974,913	)	$	1,049,925
Cancellation of shares upon officer’s resignation												(988,842	)		(17	)								(17	)
Stock-based compensation																		5,612						5,612
Net income		-			-		-			-		-			-						124,515			124,515
Balance, September 30, 2023		4,996,741		$	500		8,550,000		$	855		(2,092,619	)	$	(127	)	$	2,029,205		$	(850,398	)	$	1,180,035

 

See accompanying notes to the condensed financial statements.

 

 

SCITE, INC. 

CONDENSED STATEMENT OF CASH FLOWS

For the Period Ended September 30, 2023

(Unaudited)

 

Cash flows from operating activities:
Net income		$	124,515
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation			362
Stock based compensation			5,612
Changes in operating assets and liabilities:
Accounts receivable			45,270
Accounts payable and other current liabilities			14,105
Deferred revenue			16,201
Net cash provided by used in operating activities			206,065
Cash flows from financing activities:
Repurchase of common stock			(17	)
Net cash used in financing activities			(17	)
Net increase in cash and cash equivalents			206,048
Cash and cash equivalents, beginning of the year			1,153,292
Cash and cash equivalents, end of the period		$	1,359,340
Supplemental disclosures of cash flow information:
Cash paid during the period for:
Interest		$	-
Income taxes paid			432

 

See accompanying notes to the condensed financial statements.

 

 

SCITE, INC.

NOTES TO THE CONDENSED FINANCIAL STATEMENTS

FOR THE PERIOD ENDED SEPTEMBER 30, 2023

 

NOTE 1. NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of Business

 

Scite, Inc. is a Brooklyn, New York based start-up company that helps researchers better discover, understand and evaluate research articles through Smart-Citation which are citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence.

 

The Company’s citation platform called Scite, uses deep learning, natural language processing, and a network of experts to identify and promote reliable research by evaluating the accuracy of scientific claims. Scite, can automatically classify scientific citations as supporting, refuting or mentioning, which enables the entity to score the accuracy of scientific reports, researchers, institutions journals and scientific fields using a measure called scite.

 

The Company's customers primarily consist of research students as well as colleges and universities.

 

Basis of presentation

 

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and have been presented under the historical cost basis. In the opinion of management, the unaudited interim condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended September 30, 2023 are not necessarily indicative of the results that may be expected for the year ending June 30, 2024.

 

Use of Estimates

 

In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenue and expenses during the reported period. Actual results could differ from these estimates.

 

Revenue Recognition

 

The Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. The guidance requires the Company to recognize revenue to depict the transfer of services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those services. The guidance also requires disclosures related to the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers.

 

 

The Company’s sources of revenue during the period ended September 30, 2023, consist of Subscription and License Revenue. The Company derives its license revenue from subscription agreements with customers for access to the Company’s citation platform. The Company offers monthly or annual subscriptions/licenses to its customers. The subscription/license revenue is recognized evenly over the life of the contract as the Company considers the contract to be one performance obligation. Contract liabilities include deferred revenues related to advanced payments for license agreements which are amortized over the life of the contract which is typically one month to one year. Contract liabilities totaled $226,903 at September 30, 2023, and are expected to be recognized in the next year.

 

Income Taxes

 

The Company accounts for income taxes in accordance with FASB ASC 70, Income Taxes, which requires the recognition of deferred income taxes for differences between the basis of assets and liabilities for financial statement and income tax purposes. Deferred tax assets and liabilities represent future tax consequences for those differences, which will either be deductible or taxable when the assets and liabilities are recovered and settled. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized. Based upon all available evidence, management concluded that it was more-likely-than-not that its deferred tax assets would not be realized, and therefore a full valuation allowance was in place as of September 30, 2023. For the period ending September 30, 2023, the Company has enough outstanding net operating loss carryforwards to offset any taxable income during the period.

 

The Company follows the provisions of FASB ASC 740-10-25, which prescribes a recognition threshold and measurement attribute for the recognition and measurement of tax positions or expected to be taken in income tax returns. FASB ASC 740-10-25 also provides guidance on de-recognition of income taxes assets and liabilities, classification of current and deferred income taxes and liabilities, and accounting for interest and penalties associated with tax positions.

 

The Company has not been recently audited by the IRS or state agencies; and accordingly, the business tax returns for the past three years are open to examination. The Company has evaluated its tax positions and has concluded that they do not result in anything that would require either recording or disclosure in the financial statements based upon the criteria set forth in ASC 740.

 

Fair Value Measurements

 

The Company uses various inputs in determining the fair value of its investments and measures these assets on a recurring basis. Financial assets recorded at fair value in the balance sheets are categorized by the level of objectivity associated with the inputs used to measure their fair value. ASC Topic 820 defines the following levels directly related to the amount of subjectivity associated with the inputs:

 

Level 1		Quoted prices in active markets for identical assets or liabilities.
Level 2		Inputs, other than the quoted prices in active markets, that is observable either directly or indirectly.
Level 3		Unobservable inputs based on the Company’s assumptions.

 

 

As of June 30, 2023, the carrying value of financial assets and liabilities such as cash, accounts receivable, and accounts payable and other current liabilities approximates their fair value because of the short-term maturity of these instruments. Unless otherwise noted, it is management's opinion that the Company is not exposed to significant interest, currency or credit risks arising from these financial instruments.

 

Concentrations of Credit Risk

 

The Company's financial statements that are subject to credit risk consist primarily of cash and trade receivables. At times throughout the year, the Company's cash balances exceeded amounts insured by the Federal Deposit Insurance Company (FDIC). However, the Company believes it is not exposed to any significant credit risk related to these cash accounts.

 

At September 30, 2023 the Company had accounts receivable from three customers which comprised 19%, 15% and 10% of its accounts receivable balance, respectively. At June 30, 2023, the Company had accounts receivable from two customers which comprised 46% and 18% of its accounts receivable balance, respectively. During the period ended September 30, 2023, no customers accounted for more than 10% of the Company’s revenue.

 

Stock Based Compensation

 

The Company periodically issues stock options to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, Compensation-Stock Compensation whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.

 

The fair value of each option grant is estimated using the Black-Scholes option-pricing model. The Company is a private company and lacks company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of peer companies within the technology industry with characteristics similar to the Company. The expected term of the Company’s stock options has been determined utilizing the “simplified” method for awards that qualify as “plain vanilla” options. The expected term of stock options granted to non-employees is equal to the contractual term of the option award. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is zero, based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future.

 

During the period ended September 30, 2023, shares of common stock of the Company (the “Common Stock”) were not publicly traded. As such, during the period, the Company estimated the fair value of common stock using an appropriate valuation methodology, in accordance with the framework of the American Institute of Certified Public Accountants’ Technical Practice Aid, Valuation of Privately-Held Company Equity Securities Issued as Compensation. Each valuation methodology includes estimates and assumptions that require the Company’s judgment. These estimates and assumptions include a number of objective and subjective factors, including external market conditions, guideline public company information, the prices at which the Company sold its preferred stock to third parties in arms’ length transactions, the rights, and preferences of securities senior to the Common Stock at the time, and the likelihood of achieving a liquidity event such as an initial public offering or sale. Significant changes to the assumptions used in the valuations could result in different fair values of stock options at each valuation date, as applicable.

 

 

NOTE 2. PROPERTY AND EQUIPMENT

 

Property and equipment consist of the following at September 30, 2023 and June 30, 2023.

 

Computers		$	7,240			$	7,240
Accumulated depreciation			(4,425	)			(4,063	)
		$	2,815			$	3,177

 

Depreciation expense related to property and equipment was $362 for the period ended September 30, 2023.

 

NOTE 3. STOCK OPTION PLANS

 

In 2018, the Company established the Scite, Inc. Stock Incentive Plan ("The Plan"). Under the Plan, which covers all employees, officers and directors, as well as consultants and advisors, the Company may grant shares of Common Stock in officers and directors, as well as consultants and advisors, the Company may grant shares of Common Stock in the form of incentive stock options ("ISO") or non-statutory stock options ("NSO"). Options grants generally vest over two to four years and vest options are available to exercise for 90 days following an employee's departure. A qualified liquidation event prior to the end of the vesting schedule will trigger a full acceleration of the exercisability of outstanding incentive awards held by some or all participants, provided that the Committee, in its sole discretion, may condition such acceleration.

 

The exercise price of the options may not be granted at less than fair market value of the common stock on the date of the grant. Stock-based compensation cost is measured at the grant date, based on the fair value of the awards that are ultimately expected to vest, and recognized on a straight-line basis over the requisite service period, which is generally the vesting period.

 

The following is an analysis of options to purchase shares of the Company's stock issued and outstanding as of September 30, 2023:

 

Options outstanding at the beginning of the period			460,050
Granted			-
Options exercised			-
Forfeited			-
Options outstanding at the beginning of the period			460,050

 

 

The weighted average remaining contractual life of all options outstanding as of September 30, 2023 was 6.67 years. The remaining contractual life for options vested and exercisable at September 30, 2023 was 6.6 years. Furthermore, the aggregate intrinsic value of options outstanding as of September 30, 2023 was approximately $76,000, and the aggregate intrinsic value of options vested and exercisable as of September 30, 2023 was approximately $62,000, in each case based on the fair value of the Common Stock on September 30, 2023.

 

During the period ended September 30, 2023, the Company did not grant any options to employees. The total fair value of options that vested during the year ended September 30, 2023 was $5,612 and is included in selling, general and administrative expenses in the accompanying statement of operations. As of September 30, 2023, the amount of unvested compensation related to stock options was approximately $18,000 which will be recorded as an expense in future periods as the options vest.

 

NOTE 4. PREFERRED STOCK

 

Series Seed 1 Convertible Preferred Stock (the “Seed 1 Preferred”) consists of $0.0001 par value, 7% cumulative dividend, voting, participating preferred stock, 2,909,231 shares are authorized. As of September 30, 2023, and June 30, 2023, there were 2,909,231 shares outstanding.

 

Series Seed 2 Convertible Preferred Stock (the “Seed 2 Preferred”) consists of $0.0001 par value, 7% cumulative dividend, voting, participating preferred stock, 2,087,510 shares are authorized. As of September 30, 2023, and June 30, 2023, there were 2,087,510 shares outstanding.

 

Dividends

 

Each share is entitled to dividends as and when declared by the Board in an amount equal to 7% per annum. If an Event of Default (as defined in that certain Amended and Restated Certificate of Incorporation of Company (the “Charter”)) should occur, the rate of the Accruing Dividends (as defined in the Charter) shall automatically increase to ten percent from and after such Event of Default.

 

Voting

 

On any matter presented to the stockholders of the Company for their action or consideration at any meeting of stockholders of the Company (or by written consent of stockholders in lieu of meeting), each holder of outstanding shares of Series Seed Preferred Stock (as defined in the Charter) shall be entitled to cast the number of votes equal to the number of whole shares of Common Stock into which the shares of Series Seed Preferred Stock held by such holder are convertible as of the record date for determining stockholders entitled to vote on such matter.

 

Conversion

 

Each share of Series Seed Preferred Stock shall be convertible, at the option of the holder thereof, at any time and from time to time, and without the payment of additional consideration by the holder thereof, into such number of fully paid and nonassessable shares of Common Stock as is determined by dividing the Series Seed Original Issue Price (as defined in the Charter), by the applicable Conversion Price in effect at the time of conversion. The “Conversion Price” shall initially mean, $0.5156 with respect to the Series Seed-1 Preferred Stock (as defined in the Charter), and $0.2062 per share, with respect to the Series Seed-2 Preferred Stock (as defined in the Charter).

 

 

Liquidation

 

In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company or any Deemed Liquidation Event (as defined in the Charter), the holders of shares of Series Seed Preferred Stock then outstanding shall be entitled to be paid out of the assets of the Company available for distribution to its stockholders, and in the event of a Deemed Liquidation Event, the holders of shares of Series Seed Preferred Stock then outstanding, on a pari passu basis, shall be entitled to be paid out of the consideration payable to stockholders in such Deemed Liquidation Event or out of the Available Proceeds (as defined in the Charter), as applicable, before any payment shall be made to the holders of Common Stock by reason of their ownership thereof, an amount per share equal to the greater of (i) the applicable Original Issue Price (as defined in the Charter), plus any Accruing Dividends accrued but unpaid thereon, whether or not declared, together with any other dividends declared but unpaid thereon, or (ii) such amount per share as would have been payable had all shares of Series Seed Preferred Stock been converted into Common Stock pursuant to the agreement immediately prior to such liquidation, dissolution, winding up or Deemed Liquidation Event. If upon any such liquidation, dissolution or winding up of the Company or Deemed Liquidation Event, the assets of the Company available for distribution to its stockholders shall be insufficient to pay the holders of shares of Series Seed Preferred Stock the full amount to which they shall be entitled under the agreement, the holders of shares of Series Seed Preferred Stock shall share ratably in any distribution of the assets available for distribution in proportion to the respective amounts which would otherwise be payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid in full.

 

NOTE 5. COMMITMENTS & CONTINGENCIES

 

Sales to certain consumers may be subject to sales tax requirements and possible audits by state taxing authorities. The Company records its estimated sales tax liability and includes that amount as an accrued obligation until paid.

 

Legal Proceedings

 

From time to time, we are a party to claims and legal proceedings arising in the ordinary course of business. Although management of the Company cannot predict the ultimate outcome of these legal proceedings with certainty, it believes that the ultimate resolution of the Company’s legal proceedings, including any amounts it may be required to pay, will not have a material effect on the Company’s financial statements.

 

NOTE 6. SUBSEQUENT EVENTS

 

On November 24, 2023, the Company, Research Solutions, Inc.  (NASDAQ: RSSS) and Research Solutions Acquisition 2, LLC, a Delaware limited liability company and a wholly-owned subsidiary of the Registrant (Merger Sub) entered into an Agreement and Plan of Merger governing the Company’s merger with and into Merger Sub (the “Merger”), with Merger Sub continuing its existence under the name “Scite, LLC” (the “Surviving Entity”) as the surviving entity after the Merger and a wholly-owned subsidiary of the Registrant at the effective time of the Merger. The transaction closed on December 1, 2023.

 

 

EXHIBIT 99.3

 

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

 

On November 24, 2023, Research Solutions, Inc., a Nevada corporation (the “Registrant”, “Company”, or “Research Solutions”), Research Solutions Acquisition 2, LLC, a Delaware limited liability company and a wholly-owned subsidiary of the Registrant (“Merger Sub”), Scite, Inc. a Delaware corporation (“Scite”), and Shareholder Representative Services LLC, a Colorado limited liability company, solely in its capacity as the representative, agent and attorney-in-fact of Scite’s securityholders (the “Stockholder Representative”), entered into an Agreement of Merger and Plan of Reorganization (the “Merger Agreement”), governing Scite’s merger with and into Merger Sub (the “Merger”), with Merger Sub continuing its existence under the name “Scite, LLC” (the “Surviving Entity”) as the surviving entity after the Merger and a wholly-owned subsidiary of the Registrant. Capitalized terms used herein but not otherwise defined shall have the meanings ascribed to them in the Merger Agreement.

 

The unaudited pro forma condensed combined statements of operations for the year ended June 30, 2023 and the unaudited pro forma condensed combined balance sheet as of September 30, 2023 illustrate the estimated effect of the acquisition of Scite on the Company's financial statements. The unaudited pro forma condensed combined financial statements are based on certain estimates and assumptions made with respect to the combined operations of Research Solutions and Scite, which the Company believes are reasonable. The unaudited pro forma condensed combined financial statements are presented for illustrative purposes only and do not purport to be indicative of the results of operations or financial position of Research Solutions or Scite that actually would have been achieved had the acquisition of Scite been completed on the assumed dates, or to project the Company's results of operations or financial position for any future date or period. The unaudited pro forma condensed combined statement of operations gives pro forma effect to the acquisition as if it had occurred on July 1, 2022. The unaudited pro forma condensed combined balance sheet gives pro forma effect to the acquisition as if it had occurred on September 30, 2023.

 

The unaudited pro forma condensed combined financial information should be read in conjunction with the accompanying notes to the unaudited pro forma condensed combined financial statements. In addition, the unaudited pro forma condensed combined financial information was based on and should be read in conjunction with the following:

 

·

The Research Solutions audited consolidated financial statements as of and for the year ended June 30, 2023, and the notes thereto included in the Company's Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (“SEC”) on September 15, 2023; and

 

·

The Scite audited financial statements as of and for the year ended June 30, 2023, and the notes thereto, included in the Form 8-K/A, of which this exhibit is a part.

 

For income tax purposes, the acquisition is a taxable business combination. The Research Solutions tax basis in the assets acquired and liabilities assumed will be equal to fair market value as of the acquisition date, and thus the basis for financial reporting and tax purposes will generally be the same and no temporary differences are expected.

 

The historical consolidated financial statements of the Company have been adjusted in the unaudited pro forma condensed combined financial statements to give effect to pro forma events that are (1) directly attributable to the acquisition, (2) factually supportable, and (3) with respect to the unaudited condensed combined statement of operations, expected to have a continuing impact on the combined results. The unaudited pro forma condensed combined financial information does not reflect any operating cost synergy savings that the combined company may achieve as a result of the acquisition, or the costs necessary to achieve these operating synergies.

 

 

Research Solutions, Inc.

UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET

As of September 30, 2023

 

		RSSS				Scite				Transaction Adjustments				Pro-Forma Combined
Assets
Current Assets
Cash and equivalents			9,882,064				1,359,340				(7,305,493	)(a)			3,935,911
Accounts receivable			6,460,188				108,001				260,523	(b)			6,828,712
Prepaid expenses and other current assets			1,481,590				-				55,802	(b)			1,537,392
Total Current Assets			17,823,842				1,467,341				(6,989,168	)			12,302,015
Property and Equipment			982,625				7,240				-				989,865
Accumulated depreciation			(891,299	)			(4,424	)			-				(895,723	)
Property and Equipment, net			91,326				2,816				-				94,142
Goodwill			3,238,794				-				13,091,400	(c)			16,330,194
Intangible assets, net of accumulated amortization			2,528,259				-				8,644,167	(c)			11,172,426
Other Assets			1,033				-				-				1,033
Total Assets		$	23,683,254			$	1,470,157			$	14,746,399			$	39,899,810
Liabilities & Equity
Current Liabilities
Accounts payable and accrued expenses			8,541,564				20,016				177,680	(b)			8,739,260
Customer Advances			-				-				-				-
Deferred revenue			6,387,470				266,903				1,050,919	(b)			7,705,292
Other Liabilities			-				3,203				-				3,203
Total Current Liabilities			14,929,034				290,122				1,228,599				16,447,755
Long-Term Liabilities			1,867,043								7,194,000	(d)			9,061,043
Stockholders' Equity			6,887,177				1,180,035				6,323,800	(e)			14,391,012
Total Liabilities and Stockholders' Equity		$	23,683,254			$	1,470,157			$	14,746,399			$	39,899,810

 

 

Research Solutions, Inc.

UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS

For the Year Ended June 30, 2023

 

		RSSS				Scite				Pro-forma Adjustments				Pro-Forma Combined
Revenue		$	37,703,452			$	1,121,199			$	0			$	38,824,651
Cost of Revenue			23,002,561				199,552				-				23,202,113
Gross profit			14,700,891				921,647				-				15,622,538
Operating expenses:
Selling, general and administration			14,409,634				1,315,224				-				15,724,858
Depreciation and amortization			52,649				1,448				903,333	(f)			957,430
Total Operating Expenses			14,462,283				1,316,672				903,333				16,682,288
Income (Loss) from Operations			238,608				(395,025	)			(903,333	)			(1,059,750	)
Other Income (Expense)			338,617				(15,503	)			-				323,114
Income (loss) from operations before provision for income taxes			577,225				(410,528	)			-				(1,382,864	)
Provision for income taxes			5,602				2,276				-				7,878
Net Income (loss)		$	571,623			$	(412,804	)		$	0			$	(1,390,742	)

 

 

Research Solutions, Inc.

UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS

For the Three Months Ended September 30, 2023

 

		RSSS				Scite				Pro-forma Adjustments				Pro-Forma Combined
Revenue		$	10,060,971			$	732,634				-			$	10,793,605
Cost of Revenue			6,029,406				60,652				-				6,090,058
Gross profit			4,031,565				671,982				-				4,703,547
Operating expenses:
Selling, general and administration			5,070,897				547,675				-				5,618,572
Depreciation and amortization			59,620				362				225,833	(f)			285,815
Total Operating Expenses			5,130,517				548,037				225,833				5,904,387
Income (Loss) from Operations			(1,098,952	)			123,945				(225,833	)			(1,200,840	)
Other Income			139,365				1,002				-				140,367
Income (loss) from operations before provision for income taxes			(959,587	)			124,947				(225,833	)			(1,060,473	)
Provision for income taxes			29,402				432				-				29,834
Net Income (loss)		$	(988,989	)		$	124,515			$	(225,833	)		$	(1,090,307	)

 

Research Solutions, Inc.

NOTES TO CONDENSED COMBINED PRO FORMA UNAUDITED FINANCIAL STATEMENTS

 

Unaudited Pro Forma Condensed Financial Information

 

The preliminary allocation of the purchase price used in the unaudited pro forma condensed financial statements is based upon preliminary estimates. The preliminary estimated fair values of certain assets and liabilities have been determined by management with the assistance of a third-party valuation firm. Our estimates and assumptions are subject to change during the measurement period, which is up to one year from the acquisition date, as the Company finalizes the valuations of certain tangible and intangible assets acquired and liabilities assumed in connection with the Acquisition.

 

The pro forma condensed combined balance sheet has been adjusted to reflect the preliminary allocation by the Company's management of Scite's purchase price to identifiable tangible and intangible net assets acquired and the excess purchase price to goodwill. The preliminary purchase price allocation is based upon an estimated total purchase price of approximately $20.9 million, net of cash acquired. The consideration for this transaction includes an initial payment of $7.2 million in cash, $6.3 million in stock, a holdback of $0.2 million and a contingent earnout that has a fair value of $7.2 million as of December 31, 2023.

 

The Company’s allocation of the purchase price at December 31, 2023 included $0.1 million of receivables, $8.9 million of intangible assets and $13.1 million of goodwill. The intangible assets acquired are developed technology and customer relationships with estimated average useful lives of 3 to 10 years. The Company also assumed $1.2 million of deferred revenue as part of the acquisition.

 

Upon completion of the fair value assessment, the Company anticipates that the final purchase price allocation may differ from the preliminary assessment provided above. Any changes to the initial estimates of the fair value of the assets and liabilities will be recorded as adjustments to those assets and liabilities and the residual amounts will be allocated as an increase or decrease to goodwill. As of December 31, 2023, the Company has not completed its analysis for estimating the fair value of the assets acquired.

 

 

Pro Forma Adjustments

 

The following pro-forma adjustments are incorporated into the pro forma condensed balance sheet as of September 30, 2023 and the pro forma condensed combined statements of operations for the three months ended September 30, 2023 and for the one year ended June 30, 2023.

 

(a) To account for the cash consideration paid for the acquisition of Scite.

 

(b) To recognize the tangible assets, liabilities and deferred revenue at fair value as a result of the acquisition of Scite.

 

(c) To recognize the identified intangible assets and goodwill at fair value as a result of the acquisition of Scite.

 

(d) To recognize the earn-out at fair value as a result of the acquisition of Scite.

 

(e) To eliminate the pre-existing equity of Scite and recognize the equity portion of the consideration paid as a result of the acquisition of Scite.

 

(f) To account for the amortization of the identified intangible acquired in the acquisition of Scite.

 

 

 

v3.24.0.1

Cover	Dec. 01, 2023
Cover [Abstract]
Document Type	8-K/A
Amendment Flag	false
Document Period End Date	Dec. 01, 2023
Entity File Number	1-39256
Entity Registrant Name	Research Solutions, Inc.
Entity Central Index Key	0001386301
Entity Tax Identification Number	11-3797644
Entity Incorporation, State or Country Code	NV
City Area Code	310
Local Phone Number	477-0354
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common stock, $0.001 par value
Trading Symbol	RSSS
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false

---